Research output per year
Research output per year
Fingerprint
Dive into the research topics where Mauro Gentile is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort: Hematological Oncology
Merli, M., Ferrarini, I., Merli, F., Busca, A., Mina, R., Falini, B., Bruna, R., Cairoli, R., Marchetti, M., Romano, A., Cavo, M., Arcaini, L., Trentin, L., Cattaneo, C., Derenzini, E., Fracchiolla, N. S., Marchesi, F., Scattolin, A., Billio, A., Bocchia, M., & 20 others, 2023, In: Hematol. Oncol.. 41, 1, p. 128-138 11 p.Research output: Contribution to journal › Article › peer-review
-
Antithrombotic therapy in the postacute phase of cervical artery dissection: the Italian Project on Stroke in Young Adults Cervical Artery Dissection
Pezzini, D., Grassi, M., Zedde, M. L., Zini, A., Bersano, A., Gandolfo, C., Silvestrelli, G., Baracchini, C., Cerrato, P., Lodigiani, C., Marcheselli, S., Paciaroni, M., Rasura, M., Cappellari, M., Del Sette, M., Cavallini, A., Morotti, A., Micieli, G., Lotti, E. M., Delodovici, M. L., & 28 others, Jul 2022, In: Journal of neurology, neurosurgery, and psychiatry. 93, 7, p. 686-692 7 p.Research output: Contribution to journal › Article › peer-review
-
Antithrombotic therapy in the postacute phase of cervical artery dissection: the Italian Project on Stroke in Young Adults Cervical Artery Dissection.
Pezzini, D., Grassi, M., Luisa Zedde, M., Zini, A., Bersano, A., Carlo, G., Silvestrelli, G., Baracchini, C., Cerrato, P., Lodigiani, C., Marcheselli, S., Paciaroni, M., Rasura, M., Cappellari, M., Del Sette, M., Cavallini, A. M., Morotti, A., Micieli, G., Enrico, M. L., DeLodovici, M. L., & 28 others, May 4 2022, In: J. Neurol. Neurosurg. Psychiatry. 7 p.Research output: Contribution to journal › Article › peer-review
-
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials
Bruzzese, A., Derudas, D., Galli, M., Martino, E. A., Rocco, S., Conticello, C., Califano, C., Giuliani, N., Mangiacavalli, S., Farina, G., Lombardo, A., Brunori, M., Rossi, E., Antonioli, E., Ria, R., Zambello, R., Di Renzo, N., Mele, G., Marcacci, G., Pietrantuono, G., & 40 others, 2022, In: Hematological Oncology. 40, 4, p. 704-715 12 p.Research output: Contribution to journal › Article › peer-review
-
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Bertamini, L., Oliva, S., Rota-Scalabrini, D., Paris, L., Morè, S., Corradini, P., Ledda, A., Gentile, M., De Sabbata, G., Pietrantuono, G., Pascarella, A., Tosi, P., Curci, P., Gilestro, M., Capra, A., Galieni, P., Pisani, F., Annibali, O., Monaco, F., Liberati, A. M., & 9 others, 2022, In: J Clin Oncol. 40, 27, p. 3120-3131 12 p.Research output: Contribution to journal › Article › peer-review